Value-Based Health Care

Ropes & Gray's health care group has launched an online hub for articles, webinars, research materials and other valuable resources dedicated to value-based health care, all organized by industry segments and topics:

» Visit the value-based health care website

Will Value-based Care Save the Health Care System?

Practices: Health Care

Value-based health care is one of the most pressing topics in health care finance and policy today. Value-based payment structures are widely touted as critical to controlling runaway health care costs, but are often difficult for health care entities to incorporate into their existing infrastructures. Because value-based health care initiatives have bipartisan support, it is likely that these programs will continue to play a major role in both the public and private health insurance systems. As such, there is a pressing need to evaluate the implementation of these initiatives thus far and to discuss the direction that American health care financing will take in the coming years.

To explore this important issue, Ropes & Gray LLP and Harvard Law School’s Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics will host a full-day conference on value-based health care. This event will bring together scholars, health law practitioners, and health care entities to evaluate the impact of value-based health care on the American health care system.

This event is free and open to the public, but seating is limited and registration is required.

» Register now 

Ropes & Gray helps clients from every segment of the health care industry at every stage of their transition to value-based health care, from the initial evaluation of appropriate payment models (including all CMS innovation initiatives) to network formation, integration and contracting.  For insights on the legal and regulatory developments in connection to value-based health care, please visit our dedicated microsite.

The event is sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, with support from the Oswald DeN. Cammann Fund and Ropes & Gray LLP.